SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration
- Matthew D. Figley
- , Weixi Gu
- , Jeffrey D. Nanson
- , Yun Shi
- , Yo Sasaki
- , Katie Cunnea
- , Alpeshkumar K. Malde
- , Xinying Jia
- , Zhenyao Luo
- , Forhad K. Saikot
- , Tamim Mosaiab
- , Veronika Masic
- , Stephanie Holt
- , Lauren Hartley-Tassell
- , Helen Y. McGuinness
- , Mohammad K. Manik
- , Todd Bosanac
- , Michael J. Landsberg
- , Philip S. Kerry
- , Mehdi Mobli
- Department of Genetics
- Institute of Clinical and Translational Sciences (ICTS)
- Center of Regenerative Medicine
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- McDonnell Genome Institute (MGI)
- Siteman Cancer Center
- COVID-19 Researchers
- Department of Developmental Biology
- Bursky Center for Human Immunology and Immunotherapy
- DBBS - Molecular Cell Biology
- DBBS - Developmental, Regenerative and Stem Cell Biology
- DBBS - Molecular Genetics and Genomics
- DBBS - Neurosciences
- Hope Center for Neurological Disorders
- Brain Tumor Center
- Intellectual and Developmental Disabilities Research Center (IDDRC)
Research output: Contribution to journal › Article › peer-review
234
Link opens in a new tab
Scopus
citations